Brief: Gland Pharma Q4 Consol Net Profit 1.87 Billion Rupees
20/05/2025 12:36
May 20 (Reuters) - Gland Pharma Ltd GLAD.NS: GLAND PHARMA Q4 CONSOL NET PROFIT 1.87 BILLION RUPEES; IBES EST. 2.29 BILLION RUPEES GLAND PHARMA Q4 CONSOL REVENUE FROM OPERATIONS 14.25 BILLION RUPEES; IBES EST. 15.68 BILLION RUPEES GLAND PHARMA - DIVIDEND OF 18 RUPEES PER SHARE Source text: [ID:] Further company coverage: GLAD.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Gland Pharma
See all newsIndia Stocks: Indian shares open higher as Fed-hike fears, oil prices ease; financials lead
India Stocks: Indian shares poised to rebound as Fed-hike fears, oil prices ease
Brief: Gland Pharma Approves $21 Million Investment In Gland Pharma Usa
Brief: Fosun Pharma Says Unit Sold Gland Pharma Shares for $294 Mln
India's Gland Pharma gains on successful completion of US FDA probe at Visakhapatnam plant